Chargement en cours...
Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
PURPOSE: Recombinant hCG (r‐hCG) was approved in Japan in 2016. As a prerequisite for a Phase III study in Japan related to this approval, the pharmacokinetic (PK) profile of r‐hCG was investigated. METHODS: An open‐label, partly randomized, single‐center, single‐dose, group‐comparison, Phase I PK‐b...
Enregistré dans:
| Publié dans: | Reprod Med Biol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768983/ https://ncbi.nlm.nih.gov/pubmed/29371821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmb2.12066 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|